Enrico Selvi

2.4k total citations
64 papers, 1.6k citations indexed

About

Enrico Selvi is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Enrico Selvi has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 15 papers in Pathology and Forensic Medicine and 13 papers in Immunology. Recurrent topics in Enrico Selvi's work include Systemic Sclerosis and Related Diseases (12 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Lupus Erythematosus Research (9 papers). Enrico Selvi is often cited by papers focused on Systemic Sclerosis and Related Diseases (12 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Lupus Erythematosus Research (9 papers). Enrico Selvi collaborates with scholars based in Italy, Switzerland and Germany. Enrico Selvi's co-authors include Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi‐Pasini, Mauro Galeazzi, Sauro Lorenzini, Stefania Bisogno, Maurizio Acampa, Mariarita Natale, Francesca Guideri and Roberta Maggio and has published in prestigious journals such as The Lancet, Free Radical Biology and Medicine and The American Journal of Cardiology.

In The Last Decade

Enrico Selvi

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrico Selvi Italy 26 437 363 353 253 215 64 1.6k
Akiko Sekiguchi Japan 23 292 0.7× 615 1.7× 120 0.3× 181 0.7× 181 0.8× 87 1.5k
Elisabetta Trabetti Italy 29 430 1.0× 490 1.3× 341 1.0× 223 0.9× 45 0.2× 66 2.3k
Allen P. Yates United Kingdom 25 477 1.1× 536 1.5× 213 0.6× 179 0.7× 100 0.5× 51 2.4k
Ulf Janssen Germany 16 382 0.9× 213 0.6× 67 0.2× 134 0.5× 86 0.4× 24 1.4k
Yuliya Lytvyn Canada 23 488 1.1× 321 0.9× 83 0.2× 93 0.4× 173 0.8× 90 1.9k
Torsten Kirsch Germany 25 759 1.7× 213 0.6× 61 0.2× 267 1.1× 107 0.5× 41 1.9k
Yufeng Huang United States 22 667 1.5× 603 1.7× 73 0.2× 112 0.4× 74 0.3× 57 2.0k
Chih‐Chang Wei United States 28 807 1.8× 888 2.4× 68 0.2× 237 0.9× 134 0.6× 50 2.0k
Srikanth Givvimani United States 25 719 1.6× 367 1.0× 458 1.3× 80 0.3× 169 0.8× 50 1.8k
Helmut Schatz Germany 14 417 1.0× 143 0.4× 115 0.3× 184 0.7× 112 0.5× 31 1.7k

Countries citing papers authored by Enrico Selvi

Since Specialization
Citations

This map shows the geographic impact of Enrico Selvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Selvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Selvi more than expected).

Fields of papers citing papers by Enrico Selvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Selvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Selvi. The network helps show where Enrico Selvi may publish in the future.

Co-authorship network of co-authors of Enrico Selvi

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Selvi. A scholar is included among the top collaborators of Enrico Selvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Selvi. Enrico Selvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
d’Alessandro, Miriana, Edoardo Conticini, Laura Bergantini, et al.. (2024). Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. Tissue and Cell. 90. 102516–102516.
2.
D’Alessandro, Roberto, Paolo Falsetti, Edoardo Conticini, et al.. (2023). Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography. Life. 13(2). 487–487. 5 indexed citations
3.
Coi, Alessio, Simone Barsotti, Michele Santoro, et al.. (2021). Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy). Orphanet Journal of Rare Diseases. 16(1). 90–90. 8 indexed citations
4.
Davison, Andrew, et al.. (2020). Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria – Is nitisinone the solution?. Molecular Genetics and Metabolism Reports. 23. 100588–100588. 5 indexed citations
5.
Fui, Annalisa, Laura Bergantini, Enrico Selvi, et al.. (2019). Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis. Internal Medicine Journal. 50(3). 330–336. 53 indexed citations
6.
Lazzerini, Pietro Enea, Pier Leopoldo Capecchi, Giacomo Maria Guidelli, et al.. (2016). Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date. Drug Design Development and Therapy. Volume 10. 3083–3098. 17 indexed citations
7.
Galeazzi, Mauro, et al.. (2016). Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?. PubMed. 18(3-4). 156–8. 6 indexed citations
8.
Lazzerini, Pietro Enea, Pier Leopoldo Capecchi, Iacopo Bertolozzi, et al.. (2016). Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Frontiers in Cardiovascular Medicine. 3. 31–31. 15 indexed citations
9.
Galeazzi, M., L. Bazzichi, Gian Domenico Sebastiani, et al.. (2014). A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.. PubMed. 16(10). 666–666. 27 indexed citations
10.
Lazzerini, Pietro Enea, Alessandra Gamberucci, Pier Leopoldo Capecchi, et al.. (2013). The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF‐α. European Journal of Immunology. 44(1). 227–238. 25 indexed citations
11.
Giustarini, Daniela, Isabella Dalle‐Donne, Sauro Lorenzini, et al.. (2012). Protein thiolation index (PTI) as a biomarker of oxidative stress. Free Radical Biology and Medicine. 53(4). 907–915. 36 indexed citations
12.
Millucci, Lia, Adriano Spreafico, Laura Tinti, et al.. (2012). Alkaptonuria is a novel human secondary amyloidogenic disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(11). 1682–1691. 63 indexed citations
13.
Lazzerini, Pietro Enea, Mariarita Natale, Elena Gianchecchi, et al.. (2011). Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system. Journal of Molecular Medicine. 90(3). 331–342. 42 indexed citations
14.
Laschi, Marcella, Laura Tinti, Daniela Braconi, et al.. (2011). Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: Implications in alkaptonuria. Journal of Cellular Physiology. 227(9). 3254–3257. 44 indexed citations
15.
Malandrini, Alessandro, et al.. (2010). Transient “sicca syndrome” during phenobarbital treatment. Journal of the Neurological Sciences. 300(1-2). 164–164. 9 indexed citations
16.
Selvi, Enrico, Alfiya Akhmetshina, Katrin Palumbo, et al.. (2010). The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model. Annals of the Rheumatic Diseases. 70(4). 695–699. 38 indexed citations
17.
Tinti, Laura, Adriano Spreafico, Daniela Braconi, et al.. (2010). Evaluation of antioxiodant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. Journal of Cellular Physiology. 225(1). 84–91. 43 indexed citations
18.
Lazzerini, Pietro Enea, Sauro Lorenzini, Enrico Selvi, et al.. (2008). Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients.. PubMed. 25(5). 696–700. 41 indexed citations
19.
Capecchi, Pier Leopoldo, Alessandra Gamberucci, Pietro Enea Lazzerini, et al.. (2008). Human rheumatoid synoviocytes express functional P2X7 receptors. Journal of Molecular Medicine. 86(8). 937–949. 45 indexed citations
20.
Selvi, Enrico, et al.. (2003). Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Annals of the Rheumatic Diseases. 62(5). 460–464. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiko Sekiguchi Breakdown of academic impact, for papers by Elisabetta Trabetti Breakdown of academic impact, for papers by Allen P. Yates Breakdown of academic impact, for papers by Ulf Janssen Breakdown of academic impact, for papers by Yuliya Lytvyn Breakdown of academic impact, for papers by Torsten Kirsch Breakdown of academic impact, for papers by Yufeng Huang Breakdown of academic impact, for papers by Chih‐Chang Wei Breakdown of academic impact, for papers by Srikanth Givvimani Breakdown of academic impact, for papers by Helmut Schatz
Rankless by CCL
2026